Cronos Group (TSE:CRON) Stock Price Down 5.2% - Time to Sell?

Key Points

• Cronos Group Inc. experienced a significant stock price decline of 5.2%, trading as low as C$3.28 during mid-day on Friday.
• The company has a market capitalization of C$868.77 million and reported a P/E ratio of -18.31.
• Cronos Group, based in Toronto, specializes in cultivating and selling medicinal and recreational cannabis, with international operations including exports to Poland and Germany.

Cronos Group Inc. (TSE:CRON - Get Free Report)'s share price dropped 5.2% on Friday . The company traded as low as C$3.28 and last traded at C$3.29. Approximately 335,215 shares were traded during mid-day trading, an increase of 79% from the average daily volume of 186,995 shares. The stock had previously closed at C$3.47.

Cronos Group Trading Down 2.6%

The firm has a market cap of C$884.62 million, a P/E ratio of -18.64, a P/E/G ratio of 0.12 and a beta of 1.02. The business's 50-day moving average is C$2.85 and its two-hundred day moving average is C$2.73. The company has a debt-to-equity ratio of 0.17, a current ratio of 24.24 and a quick ratio of 24.01.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.